{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:29:23Z","timestamp":1793852963547,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC1200100"],"award-info":[{"award-number":["2020YFC1200100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.tmaid.2024.102735","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:48:30Z","timestamp":1720568910000},"page":"102735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: A multi-center cross-sectional study in China"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1145-1221","authenticated-orcid":false,"given":"Qisheng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenggang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2024.102735_bib1","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001689","article-title":"ICTV virus Taxonomy Profile: Rhabdoviridae 2022","volume":"103","author":"Walker","year":"2022","journal-title":"J Gen Virol"},{"key":"10.1016\/j.tmaid.2024.102735_bib2","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018 - recommendations","volume":"36","author":"World Health","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102735_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1016\/j.tmaid.2024.102735_bib4","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.tmaid.2024.102735_bib5","series-title":"WHO expert consultation on rabies: third report","year":"2018"},{"issue":"8","key":"10.1016\/j.tmaid.2024.102735_bib6","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1080\/21645515.2021.1883388","article-title":"Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: a non - randomized, comparative controlled study","volume":"17","author":"Haradanahalli","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.tmaid.2024.102735_bib7","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1001\/jama.1976.03270250019017","article-title":"Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum","volume":"236","author":"Bahmanyar","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2024.102735_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-1157(78)80007-9","article-title":"Immunization against rabies with rabies immune globulin, human (RIGH), and a human diploid cell strain (HDCS) rabies vaccine","volume":"6","author":"Kuwert","year":"1978","journal-title":"J Biol Stand"},{"key":"10.1016\/j.tmaid.2024.102735_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0092-1157(89)90032-2","article-title":"Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects","volume":"17","author":"Aoki","year":"1989","journal-title":"J Biol Stand"},{"key":"10.1016\/j.tmaid.2024.102735_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1045-1056(05)80048-X","article-title":"Rabies neutralizing antibody in serum of children compared to adults following post-exposure prophylaxis","volume":"20","author":"Aoki","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.tmaid.2024.102735_bib11","first-page":"461","article-title":"The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment","volume":"24","author":"Wasi","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.tmaid.2024.102735_bib12","first-page":"23","article-title":"Five-year longitudinal study of efficacy and safety of purified Vero cell rabies vaccine for post-exposure prophylaxis of rabies in Indian population","volume":"29","author":"Seghal","year":"1997","journal-title":"J Commun Dis"},{"key":"10.1016\/j.tmaid.2024.102735_bib13","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2024.102735_bib14","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/S0264-410X(01)00238-9","article-title":"Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine","volume":"19","author":"Jones","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102735_bib15","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102735_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/cid\/ciad304","article-title":"Side-by-side comparative study of the immunogenicity of the intramuscular and intradermal rabies post-exposure prophylaxis regimens in a Cohort of Suspected rabies virus exposed individuals","volume":"77","author":"Auerswald","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.tmaid.2024.102735_bib17","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1080\/21645515.2021.1906601","article-title":"Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China","volume":"17","author":"Hu","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.tmaid.2024.102735_bib18","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2009.09.029","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals","volume":"27","author":"Rupprecht","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102735_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.15585\/mmwr.mm7118a2","article-title":"Use of a Modified Preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the advisory committee on immunization practices - United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmaid.2024.102735_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0001-706X(00)00107-8","article-title":"Diffusion and fate of intramuscularly injected human rabies immune globulin","volume":"76","author":"Saesow","year":"2000","journal-title":"Acta Trop"},{"key":"10.1016\/j.tmaid.2024.102735_bib21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00705-017-3263-y","article-title":"Role of systemic injection of rabies immunoglobulin in rabies vaccination","volume":"162","author":"Wu","year":"2017","journal-title":"Arch Virol"},{"key":"10.1016\/j.tmaid.2024.102735_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0934-8840(89)80033-7","article-title":"Post exposure studies with human diploid cell rabies vaccine and purified chick embryo cell vaccine: comparative serological responses in man","volume":"271","author":"Madhusudana","year":"1989","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.tmaid.2024.102735_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1017\/S0022172400066286","article-title":"Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens","volume":"96","author":"Suntharasamai","year":"1986","journal-title":"J Hyg"},{"key":"10.1016\/j.tmaid.2024.102735_bib24","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/S0264-410X(00)00054-2","article-title":"Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy","volume":"18","author":"Strady","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102735_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2027714","article-title":"Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis","volume":"18","author":"Wang","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.tmaid.2024.102735_bib26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4269\/ajtmh.1985.34.633","article-title":"Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries","volume":"34","author":"Bernard","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2024.102735_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102550","article-title":"mRNA vaccines as an armor to combat the infectious diseases","volume":"52","author":"Priyanka","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2024.102735_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115597","article-title":"Nanovaccines: a game changing approach in the fight against infectious diseases","volume":"167","author":"Priyanka","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.tmaid.2024.102735_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2023.101098","article-title":"Tackling rabies by one health approach: Pitfalls on the road to global eradication","volume":"52","author":"Shafaati","year":"2023","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.tmaid.2024.102735_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.46234\/ccdcw2021.201","article-title":"Epidemiological study of outpatients in rabies post-exposure prophylaxis clinics - Tianjin Municipality, China, 2020","volume":"3","author":"Liu","year":"2021","journal-title":"China CDC Wkly"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893924000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893924000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T09:50:44Z","timestamp":1722073844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893924000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":30,"alternative-id":["S1477893924000516"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2024.102735","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of 4-dose Essen intramuscular regimen for rabies post-exposure prophylaxis: A multi-center cross-sectional study in China","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2024.102735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102735"}}